Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants
Clinical trial NCT02706834 · COMPLETED
Trial details
- NCT number
- NCT02706834
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-06-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.